Loading viewer...
investor_presentation
Format: PDF investor_presentation
SKAN Group AG presented an investor overview of contamination risks in biopharmaceutical manufacturing. The presentation covers key safety challenges in pharmaceutical production, including air particles, raw materials, and personnel contamination sources across injectable drugs, cancer therapies, cell & gene therapy, vaccines, and hormone products.
investor_presentation
52 Pages
Purmo Group
Weatherford International Investor Presentation — July 2022
investor_presentationinvestor_presentation
16 Pages
Weatherford International plc